NCT06274944

Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study

Name: Clinical Trial NCT06274944
Creator: University of Minnesota
Keywords: Premature Birth, nasogastric tube placement pH confirmation device, device, clinical trial, United States of America

University of Minnesota·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Premature Birth
Drug/Device/Intervention: nasogastric tube placement pH confirmation device
Study type: Observational
Intervention type: device

Sponsor & location

Primary sponsor: University of Minnesota
Location: Minneapolis, United States of America

Timeline & enrollment

Phase: N/A
Start date: Feb 12, 2024
End date: Jan 31, 2025
Enrollment: 30 participants

Primary outcome

PH reading comparison

Summary

This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.

ICD-10 classifications

Fetus and newborn affected by precipitate deliveryPreterm delivery without spontaneous labourDisorders related to short gestation and low birth weight, not elsewhere classifiedOther preterm infantsPreterm spontaneous labour with preterm delivery

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06274944
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06274944 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Minnesota and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.